cleft lip: ['Congenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519447 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
625 |
4. Check minimum number of eventsNone |
625 |
5. Include endpointsNone |
625 |
6. Filter based on genotype QC (FinnGen only) |
625 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Cleft lip, lip and palate or palate
based on the number of shared cases.
Similar with more cases:
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8348 | 4172 | 4162 |
| Only index persons | 6932 | 3502 | 3430 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.12 | 0.12 |
| Only index persons | 0.13 | 0.13 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 1.21 | 1.31 | 1.00 |
| Only index persons | 1.51 | 1.76 | 1.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 625 | 388 | 237 |
| Unadjusted period prevalence (%) | 0.12 | 0.13 | 0.10 |
| Median age at first event (years) | 2.80 | 2.67 | 3.02 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 574
- Matched controls
- 5748
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q35.1
ICD-10 Finland
Cleft hard palate
+∞
184.6
167
*
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
+∞
176.4
160
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
+∞
138.2
127
*
74920
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis
+∞
94.4
88
*
4364
FHL
Pharyngeal tongue plastic
951.8
85.9
82
*
7490A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
+∞
81.2
76
*
4362
FHL
Nozzle reconstruction
+∞
70.3
66
*
7492A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]
+∞
64.8
61
*
4361
FHL
Lip plastic or reconstruction due to cleft lip
+∞
62.7
59
*
4122
FHL
Tympanostomy (tympanic tube)
14.5
59.0
103
85
Q37.0
ICD-10 Finland
Cleft hard palate with bilateral cleft lip
+∞
57.2
54
*
EAB30
NOMESCO Finland
Correction of cleft lip
+∞
55.1
52
*
Q35.9
ICD-10 Finland
Cleft palate, unspecified
+∞
52.9
50
*
Q35.71
ICD-10 Finland
Submucous cleft palate
+∞
49.7
47
*
74929
ICD-8 Finland
Cleft palate and cleft lip, Unspecified
+∞
48.6
46
*
SBB10
NOMESCO Finland
Teeth copy
6.1
48.0
145
299
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
9.2
44.7
98
125
7490C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS SUBMUCOSAE]
+∞
42.2
40
*
7490B
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]
+∞
41.1
39
*
Q36.9
ICD-10 Finland
Cleft lip, unilateral
+∞
40.1
38
*
74924
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis bilateralis
+∞
40.1
38
*
4368
FHL
Closing the fistula of the mouth
+∞
40.1
38
*
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
7.4
39.7
100
158
4367
FHL
Bone transfer to the upper jaw
+∞
37.9
36
*
ECB17
NOMESCO Finland
Operation for cleft gingiva
+∞
36.9
35
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
6.3
36.9
105
196
EB1MA
NOMESCO Finland
Cephalometry with X-ray
9.0
36.8
81
103
7492C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS BILATERALIS COMPLETA]
+∞
34.7
33
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
10.1
34.7
71
79
EEC05
NOMESCO Finland
Le Fort I osteotomy
56.3
31.7
37
7
4365
FHL
Correction of nasal deformity
+∞
31.5
30
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.5
30.7
75
112
74910
ICD-8 Finland
Cleft palate and cleft lip, Cheiloschisis unilateralis
+∞
30.5
29
*
EBB10
NOMESCO Finland
Insertion of dental implant
18.7
29.3
45
26
ZSZ10
NOMESCO Finland
Secondary repair operation
306.6
29.0
29
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
109.0
28.9
31
*
K00.00
ICD-10 Finland
Hypodontia
16.7
28.1
45
29
H65.3
ICD-10 Finland
Chronic mucoid otitis media
7.7
26.8
64
92
Q35.3
ICD-10 Finland
Cleft soft palate
+∞
26.2
25
*
EHC10
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula of palate
+∞
26.2
25
*
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
20.7
25.1
37
19
DLW00
NOMESCO Finland
Correction of cleft nose
+∞
24.1
23
*
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
6.6
23.8
63
105
1450
FHL
Otomicroscopy
20.6
23.7
35
18
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
11.5
23.5
44
41
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.1
23.4
77
168
EHC40
NOMESCO Finland
Correction of submucous cleft palate
239.0
22.8
23
*
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
13.4
22.4
39
31
EBB15
NOMESCO Finland
Insertion of dental implant abutment
26.3
22.0
30
12
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.6
21.7
66
131
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
8.8
21.3
46
56
4451
FHL
Guitar cutting
4.7
21.1
76
182
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
6.3
21.0
57
98
4366
FHL
Upper jaw scar repair surgery
+∞
21.0
20
*
74912
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathoschisis unilateralis
+∞
19.9
19
*
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
7.0
19.7
49
75
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
6.2
19.3
53
93
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
12.5
18.0
32
27
Q37.99
ICD-10 Finland
Cleft palate with cleft lip NOS
+∞
17.8
17
*
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
+∞
17.8
17
*
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
7.0
17.7
44
67
K07.14
ICD-10 Finland
Retrognaty, maxillary
22.7
17.0
24
11
Z2221
NOMESCO Finland
Medical doctor
2.3
16.9
194
1032
UDC00
NOMESCO Finland
Ear microscopy
3.9
16.4
70
197
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
16.3
230
1342
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
21.7
16.1
23
11
DLD20
NOMESCO Finland
Rhinoplasty
34.4
15.8
20
6
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
87.5
15.6
17
*
4347
FHL
Osteotomy of the upper jaw
87.5
15.6
17
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.1
14.7
88
321
ZXB10
NOMESCO Finland
Medial
19.7
14.3
21
11
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
4.8
14.3
48
107
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
6.4
14.2
37
61
9808
FHL
Bone graft
77.0
13.6
15
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
11.3
13.6
25
23
R1260
NOMESCO Finland
Evaluation of communicative skills
16.7
13.5
21
13
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
41.1
13.2
16
*
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
7.7
13.1
30
41
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
4.7
13.0
44
99
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
12.8
211
1281
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
15.9
12.7
20
13
4204
FHL
Molding of the cartilaginous part of the nose
71.5
12.6
14
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.7
12.6
90
364
7491B
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOSCHISIS UNILATERALIS INCOMPLETA]
+∞
12.5
12
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
12.3
278
1894
ZZG00
NOMESCO Finland
Graft of cartilage
38.4
12.3
15
*
SJB60
NOMESCO Finland
External device grinding and adaptation
5.3
12.2
37
74
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.1
12.1
38
79
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
21.8
12.1
17
8
SXC05
NOMESCO Finland
Other oral or dental procedure
3.2
12.1
67
230
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
15.1
11.9
19
13
4203
FHL
Mobilization and repositioning of the external pyramid
+∞
11.5
11
*
ZSZ00
NOMESCO Finland
Primary repair operation
122.3
11.5
12
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
11.4
197
1210
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
35.8
11.3
14
*
H66.9
ICD-10 Finland
Otitis media, unspecified
2.8
11.1
75
293
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
11.0
253
1715
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.5
10.9
51
155
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
10.9
10.8
20
19
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
18.2
10.8
16
9
7491A
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOSCHISIS UNILATERALIS COMPLETA]
+∞
10.4
10
*
Q35.70
ICD-10 Finland
Cleft uvula
+∞
10.4
10
*
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
26.5
9.8
13
5
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
20.4
9.8
14
7
SXC03
NOMESCO Finland
Other oral or dental procedure
13.7
9.7
16
12
ZZH22
NOMESCO Finland
Graft of patients own bone, block
55.9
9.7
11
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
55.9
9.7
11
*
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
11.6
9.6
17
15
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
30.6
9.4
12
*
Q37.3
ICD-10 Finland
Cleft soft palate with unilateral cleft lip
+∞
9.4
9
*
Q37.90
ICD-10 Finland
Unspecified cheft palate with cleft lip, unilateral
+∞
9.4
9
*
EHC30
NOMESCO Finland
Reconstruction of palate
+∞
9.4
9
*
Q35
ICD-10 Finland
Cleft palate
+∞
9.4
9
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
22.1
9.4
13
6
R4130
NOMESCO Finland
Speech therapy
6.1
9.1
24
41
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
9.1
154
927
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
19.0
9.0
13
7
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
19.0
9.0
13
7
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
8.1
8.9
19
24
EB1WA
NOMESCO Finland
NA
12.8
8.9
15
12
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
9.7
8.8
17
18
ZXA10
NOMESCO Finland
Bilateral
2.1
8.6
98
502
SPB10
NOMESCO Finland
Production of temporary crone to tooth
11.8
8.6
15
13
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
5.3
8.6
25
49
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
4.5
8.5
29
67
SPF20
NOMESCO Finland
Temporary soling for filling
20.4
8.5
12
6
H74.1
ICD-10 Finland
Adhesive middle ear disease
20.4
8.5
12
6
ECB60
NOMESCO Finland
Reconstruction of alveolus
+∞
8.3
8
*
Q36.0
ICD-10 Finland
Cleft lip, bilateral
+∞
8.3
8
*
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
3.7
8.1
34
96
ZXE00
NOMESCO Finland
One hour or less
1.7
8.1
222
1550
DCD00
NOMESCO Finland
Myringoplasty
9.1
8.1
16
18
DFF00
NOMESCO Finland
Pure tone audiometry
2.9
8.0
47
170
EBA10
NOMESCO Finland
Surgical removal of tooth
2.0
8.0
105
569
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
7.9
7.9
17
22
J01DA08
ATC
[U] cefaclor; oral
2.0
7.9
104
565
4305
FHL
Tooth extraction by cutting
11.0
7.8
14
13
SPF30
NOMESCO Finland
Soling for prothesis
11.0
7.8
14
13
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
7.7
70
325
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
18.6
7.6
11
6
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
3.8
7.6
30
81
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
3.7
7.5
31
87
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
81.1
7.4
8
*
SJC00
NOMESCO Finland
Bracket with fixed attachment
13.6
7.4
12
9
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
11.0
7.3
13
12
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.3
7.3
21
41
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
+∞
7.3
7
*
74913
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathoschisis bilateralis
+∞
7.3
7
*
7491F
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOGNATOSCHISIS UNILATERALIS INCOMPLETA]
+∞
7.3
7
*
Q37.8
ICD-10 Finland
Unspecified cleft palate with bilateral cleft lip
+∞
7.3
7
*
Q35.7
ICD-10 Finland
Cleft uvula
+∞
7.3
7
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.1
7.0
37
126
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
3.4
7.0
32
98
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
7.0
307
2403
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
14.0
6.9
11
8
H71
ICD-10 Finland
Cholesteatoma of middle ear
14.0
6.9
11
8
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
3.4
6.9
32
99
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
6.8
177
1203
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
5.8
6.8
18
32
DLD10
NOMESCO Finland
Reconstruction of cartilage and bone of nose
16.9
6.8
10
6
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
3.5
6.7
29
85
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
22.8
6.7
9
*
H65.2
ICD-10 Finland
Chronic serous otitis media
6.5
6.7
16
25
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.5
6.6
52
224
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
3.7
6.5
26
72
J34.2
ICD-10 Finland
Deviated nasal septum
3.0
6.4
35
122
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
70.6
6.4
7
*
R49.2
ICD-10 Finland
Hypernasality and hyponasality
70.6
6.4
7
*
J01DA06
ATC
[U] cefuroxime; systemic
2.0
6.3
79
420
EH1JB
NOMESCO Finland
Functional examination of palate
+∞
6.3
6
*
EAB20
NOMESCO Finland
Plastic repair of lip
+∞
6.3
6
*
4363
FHL
Hidden slit reconstruction
+∞
6.3
6
*
4379
FHL
Other measure in this category
+∞
6.3
6
*
78353
ICD-8 Finland
Symptoms referable to respiratory system, Rhinolia
+∞
6.3
6
*
H66
ICD-10 Finland
Suppurative and unspecified otitis media
3.2
6.2
30
96
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
27.0
6.2
8
*
SPF42
NOMESCO Finland
Repair of dental crown, bridge or implant structure, demanding
27.0
6.2
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
84
545
1.63
3.89
1.9
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
168
1.89
2.72
13.9
14.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
81
2.26
2.56
1.1
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
35
202
1.78
2.54
15.3
11.4
%
95.8
94.3
2.01
35
202
(3002173) Hemoglobin [Mass/volume] in Arterial blood
46
292
1.62
2.38
11.5
10.3
g/l
122.3
125.3
0.35
41
278
(3026389) Candida sp identified in Specimen by Organism specific culture
14
59
2.40
2.30
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
108
1.98
2.17
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
50
340
1.51
1.96
11.6
10.1
mmol/l
1.2
1.0
0.13
39
264
(3011397) Hemoglobin [Presence] in Urine by Test strip
131
1055
1.31
1.93
3.6
3.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
58
2.27
1.92
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
167
1399
1.26
1.80
2.3
2.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
9
36
2.52
1.74
1.2
1.2
u/l
56.0
74.9
—
9
27
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
118
1.81
1.72
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
64
853
0.72
1.70
1.3
1.2
u/ml
12.7
8.3
0.21
31
351
(3013512) EKG study
78
995
0.75
1.56
3.2
2.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
21
2.87
1.51
3.2
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
62
811
0.74
1.48
4.0
2.8
ug/g
139.1
107.7
0.37
51
637
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
30
447
0.65
1.47
2.5
3.3
%
31.3
31.2
0.02
23
312
(3000991) Gas panel - Venous blood
47
338
1.42
1.44
17.7
10.8
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
22
2.74
1.43
3.0
3.0
mmol/l
1.2
3.2
—
6
22
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
29
2.43
1.39
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
29
191
1.54
1.37
1.1
1.1
u/ml
5.1
4.9
—
7
33
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
42
2.16
1.34
1.1
3.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
43
313
1.40
1.26
17.3
9.3
mmol/l
1.1
1.3
1.15
43
298
(3026008) Bacteria identified in Urine by Culture
135
1151
1.22
1.23
2.7
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
260
2355
1.18
1.22
3.5
3.0
estimate
0.0
0.0
0.00
46
446
(42529406) Shigella sp [Presence] in Stool by Culture
9
167
0.53
1.20
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
26
2.32
1.19
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
39
2.06
1.15
6.0
4.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
35
0.00
1.15
0.0
1.1
—
1.1
—
0
15
(3000093) Morphology [Interpretation] in Blood Narrative
0
35
0.00
1.15
0.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
259
2356
1.17
1.14
5.0
4.3
estimate
0.0
0.0
0.50
46
462
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
660
1.26
1.12
2.9
2.7
e6/l
1.1
0.7
0.66
46
360
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
163
0.55
1.10
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
163
0.55
1.10
1.2
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
131
1129
1.20
1.08
3.0
3.0
e6/l
0.3
0.3
0.11
107
838
(3052851) Hemolysis interference index of Serum or Plasma
19
121
1.59
1.06
3.5
2.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
27
187
1.46
1.05
3.9
9.3
mmol/l
25.3
24.4
0.87
22
173
(3024932) HLA-DR beta [Type]
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
85
705
1.24
1.02
3.6
3.2
ng/l
271.9
702.1
0.79
50
424
(36304419) Bacteria [Presence] in Urine
132
1145
1.19
1.01
2.8
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
260
2385
1.15
1.00
3.5
3.1
estimate
0.0
0.0
0.50
45
441
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
165
1463
1.17
0.98
3.2
3.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
29
0.00
0.98
0.0
1.0
—
91.9
—
0
16
(3020891) Body temperature
19
124
1.55
0.97
4.9
5.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
52
654
0.78
0.97
2.1
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
573
1.25
0.95
2.0
2.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
26
360
0.71
0.93
1.2
1.2
—
21.1
—
0
15
(3000494) Fungus identified in Specimen by Culture
62
503
1.26
0.91
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
91
1067
0.83
0.91
1.5
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
29
2.08
0.89
1.0
1.1
miu/ml
1616.0
1610.0
—
6
29
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
709
1.21
0.87
1.7
1.6
pmol/l
440.9
34543013.7
1.07
73
634
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
394
4129
0.88
0.86
4.4
4.4
mmol/mol
38.2
38.1
0.08
379
3928
(3011288) Drugs identified in Urine by Screen method
23
320
0.71
0.86
1.4
2.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
325
3447
0.88
0.85
7.3
6.7
u/l
84.0
78.3
0.34
309
3242
(3001019) Free T4 and TSH panel - Serum or Plasma
32
421
0.75
0.85
1.4
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
28
205
1.38
0.84
2.3
3.1
ng/l
79.1
104.1
0.37
21
183
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
138
0.57
0.84
1.5
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
46
364
1.28
0.84
11.1
7.0
mmol/l
2.0
1.7
0.35
39
287
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
114
0.52
0.83
1.3
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
350
3690
0.88
0.82
3.1
3.1
u/l
37.7
38.3
0.07
339
3540
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
37
286
1.31
0.80
16.3
10.6
mmol/l
25.3
25.0
0.29
37
286
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
349
0.73
0.79
1.4
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
505
4894
1.17
0.79
11.4
10.9
mmol/l
139.5
139.6
0.05
493
4754
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
33
1.83
0.79
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
66
1.68
0.79
16.7
8.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
99
858
1.18
0.79
2.2
2.6
e6/l
9.6
7.6
0.43
91
744
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
74
871
0.83
0.79
1.3
1.3
iu/ml
18.0
23.8
0.42
22
282
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
105
1196
0.85
0.77
2.0
2.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
30
391
0.76
0.76
2.3
2.2
—
19.5
—
0
28
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
28
0.00
0.76
0.0
1.0
—
99.3
—
0
15
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
9
54
1.68
0.74
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
462
4773
0.88
0.74
3.3
3.5
mmol/l
1.5
1.5
0.04
443
4515
(3019060) Gas panel - Arterial blood
25
185
1.37
0.73
2.8
6.9
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
25
2.01
0.73
1.0
1.2
u/l
761.4
720.2
—
5
20
(3029396) Erythrocyte agglutination [Presence] in Blood
5
25
2.01
0.73
6.2
3.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
40
318
1.28
0.72
3.4
4.4
%
0.0
0.1
—
9
76
(3011412) CD3 cells [#/volume] in Blood
10
60
1.68
0.72
1.1
3.2
e9/l
1.6
1.4
—
5
30
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
122
1084
1.16
0.72
1.5
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
68
1.63
0.72
1.7
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
200
1839
1.13
0.71
3.5
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
150
1654
0.88
0.71
1.8
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
42
1.67
0.68
1.0
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
170
1552
1.13
0.68
3.6
3.6
e6/l
72.5
68.4
0.03
122
1031
(3002582) Erythrocytes [#/volume] in Urine
139
1253
1.14
0.67
3.0
3.1
e6/l
53.8
44.0
0.18
112
951
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
92
0.54
0.67
2.8
2.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
94
1.50
0.67
5.4
6.4
—
2783.5
—
0
10
(4198724)
7
43
1.63
0.67
1.7
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
44
1.60
0.65
1.9
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
119
1325
0.87
0.65
3.9
2.5
u/l
59.3
55.0
0.56
110
1238
(3012544) pH of Venous blood
45
369
1.24
0.64
9.6
7.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
45
369
1.24
0.64
9.6
6.9
kpa
5.9
5.9
0.11
45
363
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
490
0.80
0.64
1.5
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
280
0.74
0.64
1.5
1.7
mg/l
2.0
3.0
0.70
12
192
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
87
1.50
0.63
5.5
4.9
u/ml
0.2
0.3
—
6
48
(3013707) Erythrocyte sedimentation rate by Westergren method
333
3488
0.90
0.62
4.1
3.7
mm/h
9.7
8.9
0.56
315
3271
(3013826) Glucose [Moles/volume] in Serum or Plasma
267
2513
1.11
0.62
5.6
4.8
mmol/l
6.5
6.4
0.15
243
2285
(3017181) Myelocytes/100 leukocytes in Blood
43
353
1.23
0.62
3.9
4.3
%
0.7
0.8
0.16
11
102
(3004789) Transferrin [Mass/volume] in Serum or Plasma
66
566
1.19
0.61
2.7
2.4
g/l
2.3
2.4
0.65
60
522
(3042631) Mycobacterium sp identified in Specimen
5
30
1.67
0.61
2.2
2.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
40
326
1.24
0.61
8.9
6.6
kpa
4.9
4.9
0.08
40
321
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
444
4578
0.89
0.60
3.0
3.2
mmol/l
1.3
1.3
0.09
425
4324
(3028433) Virus identified in Specimen by Culture
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
485
0.81
0.60
1.1
1.2
iu/ml
123.3
163.0
0.23
20
203
(1761868) Lipid panel - Serum or Plasma
189
2035
0.90
0.60
2.3
2.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
104
1160
0.88
0.59
2.3
2.1
u/l
203.0
245.0
0.23
97
1104
(3021440) Promyelocytes/100 leukocytes in Blood
41
337
1.23
0.59
3.9
4.4
%
0.2
0.2
0.03
11
94
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
64
1.57
0.59
1.9
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
113
0.62
0.58
1.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
23
0.00
0.58
0.0
3.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
23
0.00
0.58
0.0
3.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
23
0.00
0.58
0.0
2.1
—
122.6
—
0
23
(3026493) Urate [Moles/volume] in Serum or Plasma
91
1023
0.87
0.58
2.3
2.6
umol/l
339.6
4130.7
2.88
81
927
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
471
4835
0.89
0.57
3.7
3.8
mmol/l
2.9
2.9
0.64
449
4555
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
88
0.56
0.56
2.4
2.0
g/l
129.4
132.3
—
5
67
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
55
1.46
0.56
1.6
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
61
525
1.18
0.56
1.6
1.6
nmol/l
917.4
1200.6
2.03
47
416
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
119
1310
0.89
0.55
2.1
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
619
0.84
0.55
1.6
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.2
1.5
g/l
0.9
1.0
—
6
38
(40768804) Tissue Pathology biopsy report
167
1801
0.90
0.54
1.8
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
74
649
1.16
0.54
3.0
2.8
e6/l
2.7
3.0
0.11
40
348
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
467
4792
0.90
0.54
3.4
3.6
mmol/l
4.8
4.8
0.33
447
4550
(3023103) Potassium [Moles/volume] in Serum or Plasma
503
4911
1.12
0.54
11.6
10.9
mmol/l
3.9
3.9
0.43
487
4758
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
59
681
0.85
0.53
1.8
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
39
323
1.22
0.53
3.5
4.1
%
0.1
0.6
—
9
69
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
39
1.54
0.53
1.2
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
344
3298
1.10
0.53
4.1
3.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
36
433
0.82
0.51
1.5
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
345
0.80
0.50
2.7
3.6
pmol/l
4.5
4.7
0.54
28
308
(3040151) Glucose [Moles/volume] in Capillary blood
6
41
1.47
0.50
7.2
8.9
mmol/l
5.9
6.8
—
6
35
(3003338) MCHC [Mass/volume]
492
4804
1.11
0.50
14.2
13.2
g/l
333.6
334.1
0.57
485
4772
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
21
268
0.78
0.50
5.8
1.9
u/ml
43.1
37.7
0.09
21
253
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
68
1.48
0.47
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
142
0.70
0.46
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
243
0.77
0.46
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
265
0.79
0.46
2.8
4.4
ug/l
142.0
23.8
0.38
13
210
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
81
0.61
0.46
1.2
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
84
0.59
0.45
2.2
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
84
0.59
0.45
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
439
4503
0.91
0.45
3.4
3.4
mmol/l
5.7
5.7
0.15
419
4204
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
151
0.72
0.43
1.5
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
31
1.62
0.43
13.6
13.6
%
9.3
11.6
—
5
31
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
31
1.62
0.43
1.6
5.4
—
38.1
—
0
8
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
258
1.21
0.42
1.5
1.6
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
92
0.65
0.42
4.2
3.3
nmol/l
18.5
25.1
—
6
87
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
167
1.27
0.42
1.6
1.5
u/ml
129.7
216.0
1.56
13
95
(3002523) Influenza virus A Ag [Presence] in Specimen
19
149
1.28
0.42
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
149
1.28
0.42
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
57
1.41
0.42
1.3
1.2
mu/l
17.4
46.2
—
8
50
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
27
326
0.82
0.42
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
27
326
0.82
0.42
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
27
326
0.82
0.42
1.4
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
305
1.19
0.41
1.4
1.3
miu/ml
230.3
251.2
0.15
21
152
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
3.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
27
325
0.82
0.41
1.4
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
34
1.47
0.40
1.8
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
528
5361
0.90
0.40
9.0
8.5
u/l
27.3
27.9
0.22
515
5216
(3024561) Albumin [Mass/volume] in Serum or Plasma
177
1667
1.09
0.40
5.1
5.2
g/l
36.5
37.2
0.94
168
1566
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
102
0.68
0.40
1.3
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
182
0.76
0.40
1.9
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
178
1.24
0.39
2.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
118
1272
0.91
0.39
1.3
1.4
g/l
2.1
2.2
0.11
78
788
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
36
1.39
0.38
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
36
1.39
0.38
1.2
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
67
1.35
0.38
1.3
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
316
3049
1.07
0.37
3.8
3.8
e6/l
1468.2
526.9
—
5
36
(3037522) Nuclear Ab [Titer] in Serum
68
753
0.89
0.37
1.4
1.4
titre
328.6
483.5
0.63
14
137
(3021589) Normoblasts [#/volume] in Blood
217
2275
0.93
0.37
8.7
8.2
e9/l
0.0
0.0
0.28
174
1830
(3022145) Colonoscopy Study observation
54
479
1.14
0.37
1.5
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
171
1.24
0.36
1.6
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
77
0.65
0.36
4.4
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
113
1049
1.09
0.35
2.5
2.3
mg/l
2.7
2.7
0.00
100
899
(21494755) Public health laboratory ask at order entry panel
76
833
0.90
0.35
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
319
0.84
0.35
1.7
2.2
ml/min/173m2
88.6
76.6
—
5
126
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
66
729
0.89
0.35
5.0
3.3
ng/l
1229.9
722.9
0.45
52
587
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
182
1726
1.08
0.34
8.6
6.7
mmol/l
1.2
1.2
0.70
167
1591
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
45
1.34
0.34
1.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
188
0.79
0.33
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
28
328
0.85
0.33
3.3
4.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
166
0.78
0.33
1.3
1.5
g/l
0.2
0.2
0.02
13
158
(40758558) Short blood count panel - Blood
116
1241
0.92
0.33
6.1
6.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
173
1.22
0.33
1.8
1.5
iu/ml
0.0
0.0
—
6
29
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
46
1.31
0.33
1.8
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
74
1.36
0.32
1.7
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
212
1.19
0.30
1.4
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
45
401
1.13
0.30
1.3
1.3
u/ml
261.2
276.5
0.04
39
369
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
392
1.13
0.30
1.8
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
141
0.78
0.29
1.5
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
130
1226
1.08
0.29
3.6
3.2
estimate
0.0
0.0
1.08
46
455
(3008898) HLA-B27 [Presence]
26
302
0.85
0.29
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
270
0.85
0.29
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
109
0.73
0.29
1.1
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
54
595
0.90
0.29
1.4
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
40
355
1.14
0.29
2.2
2.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
18
216
0.83
0.28
1.9
2.1
u/l
34.1
39.3
1.06
18
196
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
151
0.79
0.28
1.6
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
115
1081
1.08
0.28
2.2
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
464
4561
1.07
0.28
13.6
12.8
%
13.4
13.3
0.22
455
4489
(40761536) Microorganisms panel - Urine sediment
45
404
1.12
0.27
2.8
3.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
116
0.77
0.27
1.1
1.5
u/l
17.9
17.6
—
9
98
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
3.4
3.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
29
253
1.15
0.26
2.0
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
539
5447
0.92
0.26
9.5
9.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(4034850)
18
151
1.20
0.25
9.3
8.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
228
2202
1.06
0.25
4.0
3.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
293
1.13
0.24
3.4
5.6
mmol/l
1.1
1.3
0.15
22
207
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
78
1.29
0.24
8.7
4.3
e9/l
4.6
4.0
—
10
78
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
81
0.74
0.24
1.2
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
32
284
1.13
0.24
1.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
180
1.17
0.24
1.4
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
23
264
0.87
0.23
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
129
1228
1.06
0.23
5.3
4.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
34
304
1.13
0.23
1.0
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
231
2383
0.95
0.23
7.3
6.3
%
8.2
8.2
0.05
216
2255
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
91
0.77
0.22
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
23
263
0.87
0.22
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
40
1.25
0.22
1.2
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
79
1.27
0.22
9.0
4.6
%
59.6
57.1
—
10
79
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
127
1331
0.94
0.22
2.8
2.8
ng/l
26.4
38.9
0.40
66
644
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
137
1432
0.94
0.22
1.2
1.4
u/ml
1.1
1.9
0.78
39
350
(3015183) Erythrocyte sedimentation rate
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
199
0.85
0.22
4.0
4.2
%
94.2
93.4
0.07
17
190
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
13
107
1.22
0.21
7.4
2.2
nmol/l
0.5
0.8
1.64
13
92
(3035285) Chloride [Moles/volume] in Venous blood
5
42
1.19
0.21
4.2
2.4
mmol/l
105.8
105.9
—
5
42
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
42
1.19
0.21
4.2
2.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
42
1.19
0.21
4.2
2.4
mmol/l
4.2
4.0
—
5
42
(3030313) Adrenal Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
11
0.00
0.21
0.0
1.6
—
126.4
—
0
11
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
145
1390
1.06
0.21
2.8
2.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
73
778
0.93
0.21
1.7
1.4
nmol/l
19.9
20.7
0.18
68
678
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
222
2287
0.95
0.20
7.0
6.2
%
0.7
0.7
0.11
208
2150
(3017732) Neutrophils [#/volume] in Blood
38
345
1.11
0.20
2.2
2.2
e9/l
3.7
4.1
0.53
33
301
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
117
1.20
0.20
1.0
1.1
u/ml
2.7
1.7
—
8
60
(3009508) Creatinine [Moles/volume] in Urine
129
1234
1.06
0.20
3.2
3.4
mmol/l
8.4
8.5
0.08
114
1088
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
14
0.00
0.20
0.0
2.0
—
0.2
—
0
9
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
9
114
0.79
0.20
1.0
1.9
mmol/l
3.7
3.7
—
9
107
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
388
3944
0.96
0.19
3.8
3.9
pmol/l
14.4
14.4
0.04
368
3665
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
289
1.11
0.19
1.4
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
241
2474
0.96
0.19
6.9
6.0
%
28.9
30.0
0.93
227
2342
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
424
1.09
0.19
5.7
5.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
52
1.16
0.19
1.2
1.3
nmol/l
28.6
35.5
—
6
41
(40761535) Cells panel - Urine sediment
33
299
1.11
0.19
3.6
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
42
386
1.09
0.18
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
383
0.91
0.18
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
58
542
1.08
0.18
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
111
1062
1.05
0.18
3.9
3.2
kg/l
1.0
1.0
0.82
16
145
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
61
1.15
0.17
1.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
22
247
0.89
0.17
1.7
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
157
1.15
0.17
1.4
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
80
843
0.94
0.17
2.4
1.8
%
1.5
1.4
0.26
73
779
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
67
0.74
0.17
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
506
5106
0.95
0.17
11.1
10.5
mg/l
21.8
20.4
0.39
384
3863
(3006504) Eosinophils/100 leukocytes in Blood
231
2367
0.96
0.17
6.9
6.1
%
2.8
2.8
0.01
217
2221
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
101
1.19
0.16
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
507
5115
0.95
0.16
13.1
11.3
%
40.2
40.8
1.13
425
4292
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
111
1156
0.95
0.16
1.5
1.7
mmol/l
1.3
1.4
0.34
101
1006
(3045424) Erythrocytes [Presence] in Urine
6
78
0.77
0.15
1.5
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
80
0.75
0.15
5.5
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
164
1591
1.04
0.15
1.7
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
83
1.09
0.14
1.2
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
202
0.89
0.14
1.4
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
131
1.15
0.14
1.2
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
305
0.91
0.14
2.1
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
539
1.06
0.14
2.6
3.6
umol/l
4.8
7.5
1.81
49
452
(4094501)
8
98
0.81
0.13
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
100
0.80
0.13
1.0
2.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
94
1.17
0.13
2.1
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
110
0.82
0.13
1.1
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
452
4476
1.04
0.13
3.8
3.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
169
0.88
0.13
2.7
2.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
255
2596
0.97
0.12
6.9
6.5
e9/l
0.2
0.2
0.41
228
2286
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
28
303
0.92
0.12
2.4
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
60
571
1.06
0.12
1.8
1.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
12
137
0.87
0.12
1.7
1.3
pmol/l
61.0
53.6
0.29
12
132
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
148
1441
1.04
0.12
1.8
1.7
pmol/l
97.7
96.4
0.12
85
757
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
106
1094
0.96
0.11
1.9
2.0
mg/l
0.8
1.0
0.90
88
804
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
211
1.09
0.11
1.3
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
86
1.17
0.11
1.9
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
163
1.11
0.11
4.6
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
59
616
0.95
0.10
2.2
2.4
mmol/l
2.4
2.4
0.86
50
536
(3001122) Ferritin [Mass/volume] in Serum or Plasma
250
2461
1.03
0.10
2.9
2.8
ug/l
82.4
90.3
0.48
241
2332
(3026782) Osmolality of Urine
84
812
1.04
0.10
2.6
2.6
mosm/kgh2o
585.0
572.6
0.15
75
688
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
139
1357
1.03
0.10
1.6
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
242
2457
0.98
0.10
6.4
5.9
%
57.0
55.7
0.98
227
2328
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
16
176
0.91
0.09
10.2
10.4
mg/l
1.4
1.2
0.46
16
167
(3009466) Valproate [Moles/volume] in Serum or Plasma
10
87
1.15
0.09
2.6
6.1
umol/l
358.7
397.3
—
10
78
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
47
1.06
0.09
1.0
1.1
mg/l
302.0
211.5
—
5
41
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
155
1.10
0.09
1.5
1.5
—
240.0
—
0
7
(3050129) First trimester maternal screen panel - Serum or Plasma
38
400
0.95
0.09
1.4
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
51
532
0.95
0.09
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
292
1.06
0.08
1.5
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
90
874
1.03
0.08
1.6
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
58
1.03
0.08
1.2
1.4
—
—
—
0
0
(4035726)
34
322
1.06
0.08
1.6
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
60
0.83
0.08
1.2
2.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
36
342
1.06
0.08
23.6
13.9
inr
1.0
1.2
—
5
67
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
76
783
0.97
0.08
1.7
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
90
924
0.97
0.08
3.2
3.4
mg/l
811.7
206.6
0.49
69
628
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
197
1940
1.02
0.07
8.2
7.1
mmol/l
1.2
1.2
0.41
177
1672
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
70
0.86
0.07
1.0
1.2
—
—
—
0
0
(4268621)
6
70
0.86
0.07
1.8
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
72
0.83
0.07
1.0
1.5
—
—
—
0
0
(1002224) Polysomnography panel
28
264
1.06
0.07
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
75
1.07
0.07
1.4
3.3
u/ml
39.8
3.4
—
8
66
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
108
1.11
0.07
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
167
1697
0.98
0.07
1.8
2.1
—
—
—
0
0
(3010421) pH of Blood
7
84
0.83
0.07
2.9
2.2
ph
7.4
7.4
—
7
70
(4306422)
8
92
0.87
0.07
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
103
0.87
0.06
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
105
0.85
0.06
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
45
466
0.96
0.06
1.5
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
216
2184
0.98
0.06
5.0
6.0
umol/l
11.1
11.0
0.02
203
2074
(3013650) Neutrophils [#/volume] in Blood by Automated count
290
2876
1.02
0.05
8.1
8.8
e9/l
4.1
3.9
0.71
253
2498
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
120
1.08
0.05
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
459
4609
0.98
0.05
4.3
4.5
mu/l
1.8
1.8
0.64
443
4343
(3023511) Choriogonadotropin [Units/volume] in Urine
23
241
0.95
0.04
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
98
964
1.02
0.04
1.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
472
0.97
0.03
2.7
2.2
ug/l
0.6
0.6
0.12
25
222
(3004588) Protein electrophoresis panel - Serum or Plasma
16
169
0.95
0.03
2.1
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
46
471
0.97
0.03
1.5
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
58
569
1.02
0.03
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
221
1.04
0.03
1.6
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
159
1602
0.99
0.02
6.7
6.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
451
4497
1.01
0.02
9.4
8.7
ml/min/173m2
92.4
94.3
0.97
352
3591
(3045414) Leukocytes [Presence] in Urine
19
182
1.05
0.02
1.7
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
113
1119
1.01
0.02
4.5
3.6
ph
7.4
7.4
0.24
15
188
(4010399)
30
292
1.03
0.02
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
36
368
0.98
0.01
1.4
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
46
468
0.98
0.01
1.5
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
157
0.95
0.01
1.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
163
1.04
0.01
2.9
5.8
g/l
0.1
0.3
—
7
91
(3032080) INR in Blood by Coagulation assay
138
1371
1.01
0.01
8.6
5.9
inr
1.2
1.1
0.59
38
453
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
373
1.02
0.01
1.0
1.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
249
2498
0.99
0.01
6.7
6.1
e9/l
0.6
0.5
0.34
223
2166
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
106
0.94
0.01
1.9
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
156
0.96
0.00
1.3
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
134
1333
1.01
0.00
2.3
3.0
mmol/l
2.4
2.4
0.50
112
1214
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
184
1.03
0.00
1.3
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
193
1923
1.01
0.00
2.7
2.5
nmol/l
70.0
72.9
0.81
184
1786
(3020961) Endomysium IgA Ab [Titer] in Serum
33
336
0.98
0.00
1.1
1.1
—
195.0
—
0
6
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
234
1.03
0.00
1.6
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
589
5895
0.98
0.00
15.8
15.2
e9/l
6.7
6.7
0.32
577
5750
(3007461) Platelets [#/volume] in Blood
588
5885
0.98
0.00
15.8
15.2
e9/l
267.0
259.3
2.15
576
5749
(3020682) Albumin/Creatinine [Ratio] in Urine
97
964
1.01
0.00
3.9
4.1
mg/mmol
7.1
9.5
0.41
71
644
(3025130) Human papilloma virus identified in Specimen
11
111
0.99
0.00
1.3
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
97
1.03
0.00
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
550
1.00
0.00
1.4
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
52
519
1.00
0.00
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
628
1.00
0.00
3.3
3.2
%
17.3
20.8
1.04
21
200
(3027944) Amphetamines [Presence] in Urine
46
462
1.00
0.00
1.5
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
172
1722
1.00
0.00
3.6
3.3
u/l
84.0
31.3
0.45
164
1648
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
10
96
1.04
0.00
1.1
1.1
iu/ml
59.6
90.7
—
5
28
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
156
1.03
0.00
1.9
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
135
0.96
0.00
2.3
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
259
2591
1.00
0.00
6.6
6.1
e9/l
1.9
2.0
0.66
236
2296
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
217
1.01
0.00
1.5
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
16
157
1.02
0.00
1.6
1.3
—
71.7
—
0
18
(3023368) Bacteria identified in Blood by Culture
94
944
0.99
0.00
3.4
3.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
17
174
0.98
0.00
2.9
4.4
g/l
3.1
3.4
0.71
17
169
(3044889) 12 lead EKG panel
296
2963
1.00
0.00
2.7
2.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
63
634
0.99
0.00
5.1
4.8
mmol/l
0.8
0.8
1.07
57
605
(3036489) Thrombin time
21
212
0.99
0.00
2.4
3.6
s
22.6
21.7
0.52
21
190
(3023520) Reticulocytes [#/volume] in Blood
25
245
1.02
0.00
1.8
3.4
e9/l
98.5
72.2
0.61
16
177
(3026361) Erythrocytes [#/volume] in Blood
589
5892
0.99
0.00
15.8
15.2
e12/l
4.6
4.6
0.18
577
5751
(3022313) Gas panel - Capillary blood
24
238
1.01
0.00
4.0
5.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
42
422
0.99
0.00
2.2
2.3
u/l
5990.3
4497.0
0.14
18
180
(3030981) Hyaline casts [#/volume] in Urine by Automated count
20
204
0.98
0.00
3.2
2.6
e6/l
0.3
0.1
0.91
20
196
(3006315) Basophils [#/volume] in Blood
251
2507
1.00
0.00
6.6
6.1
e9/l
0.0
0.0
0.27
224
2175
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
15
153
0.98
0.00
1.5
1.7
pmol/l
261.3
215.3
1.07
15
146
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
12.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
15.4
—
0
7
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
12.1
—
0
7
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
96
0.94
0.00
2.8
2.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
69
0.87
0.00
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.8
—
10891.4
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(3044941) Cell count panel - Synovial fluid
5
56
0.89
0.00
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
91
0.99
0.00
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
5
0.00
0.00
0.0
3.6
—
26.6
—
0
5
(3013290) Carbon dioxide [Partial pressure] in Blood
7
70
1.00
0.00
2.9
2.3
kpa
5.1
5.0
—
7
70
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
32.8
—
0
5
(4015189)
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
64
0.94
0.00
2.0
2.9
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
49
1.02
0.00
1.0
1.2
mg/l
85.2
34.1
—
5
39
(3004616) Nuclear Ab [Presence] in Serum
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
70
1.00
0.00
2.9
2.3
kpa
10.1
9.5
—
7
70
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
5
55
0.91
0.00
1.4
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
394.4
—
0
5
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
5
0.00
0.00
0.0
3.0
—
17.0
—
0
5
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
26.3
—
0.4
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
-0.00
0.0
1.1
—
1.9
—
0
9
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
9
0.00
-0.00
0.0
3.0
—
518.6
—
0
9
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
-0.00
0.0
2.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CLEFT_LIP_CLEFT_PALATE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CLEFT_LIP_CLEFT_PALATE | 1.527 [1.11, 2.1] | 0.009 |
| Birth year | 0.998 [0.99, 1.01] | 0.627 |
During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 1650 females with Q17_CLEFT_LIP_CLEFT_PALATE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CLEFT_LIP_CLEFT_PALATE | 1.453 [1.11, 1.9] | 0.007 |
| Birth year | 0.99 [0.98, 1.0] | 0.028 |
During the follow-up period (1.1.1998 — 31.12.2019), 61 out of 1668 males with Q17_CLEFT_LIP_CLEFT_PALATE died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CLEFT_LIP_CLEFT_PALATE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.288% |
| 5 | 0.868% | 1.897% |
| 10 | 2.146% | 4.739% |
| 15 | 4.504% | 8.678% |
| 20 | 8.001% | 14.407% |
Relationships between endpoints
↥Index endpoint: Q17_CLEFT_LIP_CLEFT_PALATE – Cleft lip, lip and palate or palate
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data